| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/11/1999 | DE19740384A1 Antisense oligonucleotides specific for protein kinase C isoforms |
| 03/11/1999 | DE19739693A1 Synergistic treatment of multiple sclerosis and other neurodegenerative disorders |
| 03/11/1999 | CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile |
| 03/11/1999 | CA2302830A1 Glucose responsive .beta.-cell line |
| 03/11/1999 | CA2302451A1 Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof |
| 03/11/1999 | CA2302403A1 Sr-bi antagonists and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 03/11/1999 | CA2302195A1 Reverse phase connective tissue repair composition |
| 03/11/1999 | CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 03/11/1999 | CA2302167A1 Antisense treatment of pulmonary hypertension |
| 03/11/1999 | CA2302049A1 Kits and methods for alleviation of lower gastrointestinal disorders in a human patient |
| 03/11/1999 | CA2301981A1 Biomolecules comprising an elastomeric peptide |
| 03/11/1999 | CA2301848A1 Robinia pseudoacacia lectin and its uses |
| 03/11/1999 | CA2301846A1 Modular protein libraries and methods of preparation |
| 03/11/1999 | CA2301157A1 Conjugates that contain the homeodomain of antennapedia |
| 03/11/1999 | CA2300354A1 Modulators of dna cytosine-5 methyltransferase and methods for use thereof |
| 03/11/1999 | CA2300046A1 N-terminal modifications of rantes and methods of use |
| 03/11/1999 | CA2298601A1 Inhibitors of protein tyrosine phosphatase |
| 03/11/1999 | CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/11/1999 | CA2296723A1 Combination therapy comprising atorvastatin and an antihypertensive agent |
| 03/10/1999 | EP0900849A1 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 03/10/1999 | EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus |
| 03/10/1999 | EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus |
| 03/10/1999 | EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
| 03/10/1999 | EP0900845A2 Signal recognition particle polypeptides and polynucleotides |
| 03/10/1999 | EP0900844A2 Membrane protein of Staphylococcus aureus |
| 03/10/1999 | EP0900843A2 FfH polypeptide from Streptococcus |
| 03/10/1999 | EP0900841A1 LAG-3 splice variants |
| 03/10/1999 | EP0900804A2 Analogs for specific oligosaccharide-protein interactions and uses therefor |
| 03/10/1999 | EP0900791A1 Tetrazole derivatives and drugs containing the same as the active ingredient |
| 03/10/1999 | EP0900569A2 Therapeutic agent for herniated intervertebral disc |
| 03/10/1999 | EP0900383A1 Peptides having specific affinity to pacap type 1 receptors |
| 03/10/1999 | EP0900282A1 $i(OB) RECEPTOR ISOFORMS AND NUCLEIC ACIDS ENCODING THEM |
| 03/10/1999 | EP0900280A2 Use of a polypeptide as cell receptor for adenoviruses |
| 03/10/1999 | EP0900276A1 Novel cyclin-selective ubiquitin carrier polypeptides |
| 03/10/1999 | EP0900275A1 Methods and reagents for modulating apoptosis |
| 03/10/1999 | EP0900235A1 Fragments of cr1 and their use |
| 03/10/1999 | EP0900232A1 High molecular weight surface proteins of non-typeable haemophilus |
| 03/10/1999 | EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/10/1999 | EP0900229A1 Novel compounds |
| 03/10/1999 | EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
| 03/10/1999 | EP0900086A1 Enhancement of sleep with a growth hormone secretagogue |
| 03/10/1999 | EP0722438B1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 03/10/1999 | EP0703783A4 Hla-a2.1 binding peptides and their uses |
| 03/10/1999 | EP0644899B1 Production of recombinant human lactoferrin |
| 03/10/1999 | EP0548214B1 EXPRESSION OF MACROPHAGE INDUCIBLE PROTEINS (MIPs) IN YEAST CELLS |
| 03/10/1999 | CN1210559A Production of rDSPA 'alpha' I |
| 03/10/1999 | CN1210558A Recombinant phages |
| 03/10/1999 | CN1210459A Sustained delivery of active agent using an implantable system |
| 03/10/1999 | CN1210110A Active peptide for promoting immunization function and usage thereof |
| 03/10/1999 | CN1042397C Swine WBC interferon injection and its preparation |
| 03/10/1999 | CA2243670A1 Novel histidine kinase |
| 03/09/1999 | US5880277 Ribozyme cleavage of 5α-reductase mRNA |
| 03/09/1999 | US5880268 Modulators of the interaction between ICAM-R and αd /CD18 |
| 03/09/1999 | US5880267 Trophinin and trophinin-assisting protein agonists, antibodies and antagonists |
| 03/09/1999 | US5880265 Isolating factor viii and recombinants by anion exchange chromotography resulting in highly pure von willebrand factor having structural integrity, stability and no proteolytic degradation |
| 03/09/1999 | US5880263 Human chemotactic protein |
| 03/09/1999 | US5880262 Response regulator polypeptides from streptococcus pneumoniae; for diagnosis of bacterial infections including otitis media and meningitis; for screening of new antibiotics, bactericides |
| 03/09/1999 | US5880261 Diagnosis, and prophylactic and therapeutic treatment of conditions such as diabetes and neurological diseases such as dementia and/or parkinsonism. |
| 03/09/1999 | US5880260 Dopamine receptors and genes |
| 03/09/1999 | US5880258 Higher anti-thrombin activity by sulfating the hydroxyl group of tyrosine residues; mutant amino acid sequence allows more efficient enzyme sulfation |
| 03/09/1999 | US5880256 Inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of factor viia, factor xia, plasma kallikrein, or plasmin is indicated. |
| 03/09/1999 | US5880125 4-spiroindoline piperidines promote release of growth hormone |
| 03/09/1999 | US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome |
| 03/09/1999 | US5880105 Human galactokinase gene |
| 03/09/1999 | US5880103 Administering to mammal nucleic acid which expresses immunogenic peptide within cell to elicit t-cell mediated immune response |
| 03/09/1999 | US5880097 Tethered prodrugs |
| 03/09/1999 | US5880096 Peptides and compounds that bind to the IL-1 receptor |
| 03/09/1999 | US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 03/09/1999 | US5880094 Polypeptides that stimulate bone growth |
| 03/09/1999 | US5880093 Useful in prevention of spontaneous abortion and premature labor |
| 03/09/1999 | US5880092 Conformationally stabilized cell adhesion peptides |
| 03/09/1999 | US5880091 Glycoprotein ligand for P-selectin and methods of use thereof |
| 03/09/1999 | US5880090 Treatment of vascular graft implants with G-CSF |
| 03/09/1999 | US5879942 Processing enzyme for polypeptide |
| 03/09/1999 | US5879938 Ribozyme with increased activity by substitution of modified nucleotide into substrate binding arm or catalytic core |
| 03/09/1999 | US5879911 Cell surface protein expressed on human cortical thymocyte and their use |
| 03/09/1999 | US5879910 Hepatocyte growth factor protease domain variants |
| 03/09/1999 | US5879908 CRFG-1a, a target and marker for chronic renal failure |
| 03/09/1999 | US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 03/09/1999 | US5879898 Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors |
| 03/09/1999 | US5879896 Method of screening for inhibitors of human thyrotropin releasing hormone (TRH) receptor |
| 03/09/1999 | US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer |
| 03/09/1999 | US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia. |
| 03/09/1999 | US5879712 Introducing solution comprising alginate and drug into mixing chamber to form droplets, introducing stream of emulsifier, forming emulsion, transporting to second mixing chamber, introducing crosslinking agent to form microparticles |
| 03/09/1999 | US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors |
| 03/09/1999 | US5879681 Compounds and compositions for delivering active agents |
| 03/09/1999 | US5879680 Cloned DNA for synthesizing unique glucocerebrosidase |
| 03/09/1999 | US5879677 Method for inhibition of cerebral tissue factor mediated reperfusion damage |
| 03/09/1999 | US5879673 Administration of thrombopoietin on a single day only |
| 03/09/1999 | US5879672 Tie-2 ligand 1 |
| 03/09/1999 | US5879664 Isolated active enzyme obtained from aspergillus |
| 03/09/1999 | US5879658 Technetium-99m labeled peptides for thrombus imaging |
| 03/09/1999 | US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 03/09/1999 | US5879656 Radioactive therapeutic agent, receptor binding moiety |
| 03/09/1999 | US5879340 Applicator system with suction control |
| 03/09/1999 | CA2243656A1 Response regulator |
| 03/09/1999 | CA2105538C Differentially expressed leishmania genes and proteins |
| 03/09/1999 | CA2080355C Isolated viral protein cytokine antagonists |
| 03/09/1999 | CA2038279C Cd25 binding molecules |
| 03/09/1999 | CA1340427C Genetic modification of endothelial cells |